CASC3 and colon adenocarcinoma: In accordance to our observations in flies, treatment of the MM JJN3 (Fig. 6A1) or the colon adenocarcinoma DLD-1 (Fig. 6A2) cells with BTZ or CFZ revealed an increased specificity of CFZ (compared to BTZ) against the CT-L proteasomal activity.